Manufacture of a monoclonal antibody for use as a single-step immunoselection of blood dendritic cells aiding in the development of a patient-specific cancer vaccine (2020–2021)

Grant type:
Queensland Biomedical Voucher Program
Researchers:
  • Research Fellow
    Australian Institute for Bioengineering and Nanotechnology
  • Senior Research and Quality Assuran
    Australian Institute for Bioengineering and Nanotechnology
Funded by:
Queensland Government Department of State Development